Jac Wijkmans

Jac Wijkmans is an accomplished professional in the pharmaceutical and life sciences sectors, currently serving as Chief Scientific Officer at Flindr Therapeutics since November 2021. Wijkmans also operates as the Owner and Principal Consultant at INNTREST Consultancy BV, providing strategic R&D advice and project management services since January 2014. Previous roles include Senior Program Manager BioConjugates at Lonza, R&D Consultant at Immagene, and leadership positions in various organizations focused on gene therapy, immunotherapy, and drug development. Wijkmans holds a PhD in Organic Chemistry from Leiden University and has a robust educational background in Bio-Organic Chemistry and Chemistry, complemented by extensive experience in business development and project management in the life sciences industry.